Thylakoid proliferative glomerulonephritis is not completely curable, but active treatment can improve the symptoms, control the complications, and achieve the purpose of delaying the progression of renal function.
Glomerulonephritis with thylakoid proliferation can be seen under the light microscope as diffuse proliferation of glomerular thylakoid cells and thylakoid stroma, which can be manifested as nephrotic syndrome, i.e., large amount of proteinuria and hypoproteinemia, etc. Aggressive treatment can alleviate the symptoms of proteinuria and edema, and can effectively control the complications such as renal anemia and delay the progression of the disease, but it cannot be a complete cure.
Therapeutic drugs for thylakoid proliferative glomerulonephritis mainly include hormones and cytotoxic drugs, etc. The therapeutic effect depends on the severity of the pathological changes. The therapeutic effect is related to the severity of pathological changes. Those with mild pathologic changes have better efficacy and relatively better prognosis; those with severe pathologic changes have poor efficacy and poor prognosis, and the probability of progression to the uremic stage is greatly increased.
Patients with mesangial proliferative glomerulonephritis should go to the hospital in time and be treated under the guidance of professional physicians.